Lung cancer and past occupational exposure to asbestos role of p53 and K-ras mutations

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 4, 1999, Pages 667-674

  Husgafvel Pursiainen, Kirsti ^a   Karjalainen, Antti ^b   Kannio, Annamaria ^b   Anttila, Sisko ^b   Partanen, Timo ^b   Ojajärvi, Anneli ^b   Vainio, Harri ^b  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

ADENOCARCINOMA; ADOLESCENT; ANALYSIS OF VARIANCE; ARTICLE; FEMALE; GENETICS; HUMAN; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MUTATION; OCCUPATIONAL EXPOSURE; ONCOGENE RAS; ONSET AGE; PATHOLOGY; REGRESSION ANALYSIS; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; ULTRASTRUCTURE;

ADENOCARCINOMA; ADOLESCENT; AGE OF ONSET; ANALYSIS OF VARIANCE; ASBESTOS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; GENES, P53; GENES, RAS; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MUTATION; OCCUPATIONAL EXPOSURE; REGRESSION ANALYSIS; SMOKING;

EID: 0033110880     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.4.3404     Document Type: Article

References (58)

1. Doll, R., and R. Peto. 1981. The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today. Oxford University Press, Oxford, New York.
2. IARC. 1987. Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monograph Vol. 1 to 42, Suppl. 7. International Agency for Research on Cancer, Lyon, France. 106-116.
3. Wilkinson, P., D. M. Hansell, J. Janssens, M. Rubens, R. M. Rudd, A. Newman-Taylor, and C. McDonald. 1995. Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph? Lancet 345:1074-1078.
4. Karjalainen, A. 1997. Asbestos: a continuing concern. Scand. J. Work Environ. Health 23:81-82.
5. Anonymous. 1992. Asbestos production: the chrysotile crisis. Industrial Minerals May:41-53.
6. Levy, B. S., and A. Seplow. 1992. Asbestos-related hazards in developing countries. Environ. Res. 59:167-174.
7. Hammond, E. C., I. J. Selikoff, and H. Scidman. 1979. Asbestos exposure, cigarette smoking and death rates. Ann. NY Acad. Sci. 330:390-473.
8. IARC. 1996. In Mechanisms of Fibre Carcinogenesis. A. B. Kane, P. Boffetta, R. Saracci, and J. D. Wilbourn, editors. International Agency for Research on Cancer, Lyon. IARC Scientific Publications No. 140.
9. Hughes, J. M., and H. Weill. 1991. Asbestosis as a precursor of asbestos-related lung cancer: results of a prospective mortality study. Br. J. Ind. Med. 48:229-233.
10. Vainio, H., and P. Boffetta. 1994. Mechanisms of the combined effect of asbestos and smoking in the etiology of lung cancer. Scand. J. Work Environ. Health 20:235-242.
11. Jaurand, M.-C. 1997. Mechanisms of fiber-induced genotoxicity. Environ. Health Perfect. 105:1073-1084.
12. Walker, C., J. Everitt, and J. C. Barrett. 1992. Possible cellular and molecular mechanisms for asbestos Carcinogenicity. Am. J. Ind. Med. 21:253-273.
13. Heintz, N. H., Y. M. W. Janssen, and B. T. Mossman. 1993. Persistent induction of c-fos and c-jun expression by asbestos. Proc. Natl. Acad. Sci. USA 90:3299-3303.
14. 2 is directly related to increased proliferation and transformation of tracheal epithelial cells. Cancer Res. 55:2723-2726.
15. Hei, T. K., L. J. Wu, and C. O. Piao. 1997. Malignant transformation of immortalized human bronchial epithelial cells by asbestos fibers. Environ. Health Perspect. 105:1085-1088.
16. Greenblatt, M. S., W. P. Bennett, M. Hollstein, and C. C. Harris. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:4855-1878.
17. Puisieux, A., S. Lim, J. Groopman, and M. Ozturk. 1991. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res. 51:6185-6189.
18. Biggs, P. J., W. Warren, S. Venitt, and M. R. Stratton. 1993. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer. Mutagenesis 8:275-283.
19. Craighead, J. E., J. L. Abraham, A. Churg, F. H. Y. Green, J. Kleinerman, P. C. Pratt, T. A. Seemayer, V. Vallyathan, and H. Weill. 1982. The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Arch. Pathol. Lab. Med. 106: 544-596.
20. Karjalainen, A., S. Anttila, L. Heikkilä, P. Karhunen, and H. Vainio. 1993. Asbestos exposure among Finnish lung cancer patients: occupational history and fiber concentration in lung tissue. Am. J. Ind. Med. 23:461-171.
21. Karjalainen, A., E. Vanhala, P. Karhunen, K. Lalu, A. Penttilä, and A. Tossavainen. 1994. Asbestos exposure and pulmonary fiber concentration of 300 Finnish urban men. Scand. J. Work Environ. Health 20:34-41.
22. Ridanpää, M., A. Karjalainen, S. Anttila, H. Vainio, and K. Husgafvel-Pursiainen. 1994. Genetic alterations in p53 and K-ras in lung cancer in relation to histopathology of the tumor and smoking history of the patient. Int. J. Oncol. 5:1109-1117.
23. Kannio, A., M. Ridanpää, H. Koskinen, T. Partanen, S. Anttila, Y. Collan, E. Hietanen, H. Vainio, and K. Husgafvel-Pursiainen. 1996. A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos. Cancer Epidemiol. Biomarkers Prev. 5:33-39.
24. Husgafvel-Pursiainen, K., A.-M. Kannio, P. Oksa, T. Suitiala, H. Koskinen, R. Partanen, K. Hemminki, S. Smith, R. Rosenstock-Leiby, and P. W. Brandt-Rauf. 1997. Mutations, tissue accumulations, and serum levels of p53 in patients with occupational cancers from asbestos and silica exposure. Environ. Mol. Mutagen. 30:224-230.
25. Ridanpää. M., and K. Husgafvel-Pursiainen. 1993. Denaturing gradient gel electrophoresis (DGGE) assay for K-ras and N-ras genes: detection of K-ras point mutations in human lung tumour DNA. Hum. Mol. Genet. 2:639-644.
26. Husgafvel-Pursiainen, K., P. Hackman, M. Ridanpää, S. Anttila, A. Karjalainen, T. Partanen, O. Taikina-aho, L. Heikkilä, and H. Vainio. 1993. K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos. Int. J. Cancer 53:250-256.
27. Nuorva, K., R. Mäkitaro, E. Huhti, D. Kamel, K. Vähäkangas, R. Bloigu, Y. Soini, and P. Pääkkö. 1994. p53 protein accumulation in lung carcinomas of patients exposed to asbestos and tobacco smoke. Am. J. Respir. Crit. Care Med. 150:528-533.
28. Guinee, D. G., W. D. Travis, G. E. Trivers, V. M. G. De Benedetti, H. Cawley, J. A. Welsh, W. P. Bennett, J. Jett, T. V. Colby, H. Tazelaar, S. L. Abbondanzo, P. Pairolero, V. Trastek, N. E. Caporaso, L. A. Liotta, and C. C. Harris. 1995. Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression. Carcinogenesis 16:993-1002.
29. Wang, X., D. C. Christiani, J. K. Wiencke, M. Fischbein, X. Xu, T. J. Cheng, E. Mark, J. C. Wain, and K. T. Kelsey. 1995. Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure. Cancer Epidemiol. Biomarkers Prev. 4:543-548.
30. Harty, L. C., D. G. Guinee, Jr., W. D. Travis, W. P. Bennett, J. Jett, T. V. Colby, H. Taxelaar, V. Trastek, P. Pairolero, L. A. Liotta, C. C. Harris, and N. E. Caporaso. 1996. P53 mutations and occupational exposures in a surgical series of lung cancers. Cancer Epidemiol. Biomarkers Prev. 5:997-1003.
31. Pairon, J. C., M. A. Billon-Galland, Y. Iwatsubo, I. Abd-AI-Satnad, P. Brochard, C. Danel, F. Galateau-Salle, B. Housset, M. Letourneux, R. Lubin, I. Monnet, J. F. Regnard, M. Riquet, and T. Soussi. 1997. P53 expression and asbestos exposure in lung cancer. Eur. Respir. J. 10:S111. (Abstr.)
32. Mishra, A., J.-Y. Liu, A. R. Brody, and G. F. Morris. 1997. Inhaled asbestos fibers induce p53 expression in the rat lung. Am. J Respir. Cell Mol. Biol. 16:479-485.
33. Unfried, K., N. Kociok, M. Roller, J. Friemann, F. Pott, and W. Dehnen. 1997. P53 mutations in tumours induced by intraperitoneal injection of crocidolite asbestos and benzo[a]pyrene in rats. Exp. Toxic. Pathol. 49: 181-187.
34. Hainaut, P., T. Hernandez, A. Robinson, P. Rodriguez-Tome, T. Flores, M. Hollstein, C. C. Harris, and R. Montesano. 1998. IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res. 26:205-213.
35. Denissenko, M. F., A. Pao, M.-S. Tang, and G. P. Pfeifer. 1996. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274:430-432.
36. Mossman, B. T., J. Bignon, M. Corn, A. Seaton, and J. B. L. Gee. 1990. Asbestos: scientific developments and implications for public policy. Science 247:294-301.
37. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N. Engl. J. Med. 4:1198-1203.
38. Fung, H., Y. W. Kow, B. Van Houten, and B. T. Mossman. 1997. Patterns of 8-hydroxydeoxyguanosine formation in DNA and indications of oxidative stress in rat and human pleural mesothelial cells after exposure to crocidolite asbestos. Carcinogenesis 18:825-832.
39. Priemé, H., S. Loft, M. Klarlund, K. Grønbaek, P. Tøonesen, and H. E. Poulsen. 1998. Effect of smoking cessation on oxidative DNA modification estimated by 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion. Carcinogenesis 19:347-351.
40. Cheng, K. C., D. S. Cahill, H. Kasai, S. Nishimura, and L. A. Loeb. 1992. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G→T and A→C substitutions. J. Biol. Chem. 267:166-172.
41. Hussain, S. P., F. Aguilar, P. Amstad, and P. Cerutti. 1994. Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. Oncogene 9:2277-2281.
42. Bérubé, K. A., T. R. Quinlan, H. Fung, J. Magae, P. Vacek, D. J. Taatjes, and B. T. Mossman. 1996. Apoptosis is observed in mesothelial cells after exposure to crocidolite asbestos. Am. J. Respir. Cell Mol. Biol. 15:141-147.
43. Goldberg, J. L., C. L. Zanella, Y. M. W. Janssen, C. R. Timblin, L. A. Jiminez, P. Vacek, D. J. Taatjes, and B. T. Mossman. 1997. Novel cell imaging techniques show induction of apoptosis and proliferation in mesothelial cells by asbestos. Am. J. Respir. Cell Mol. Biol. 17:265-271.
44. Levine, A. J. 1997. P53, the cellular gatekeeper for growth and division. Cell 88:323-331.
45. Janssen, Y. M. W., N. H. Heintz, and B. T. Mossman. 1995. Induction of c-fos and c-jun proto-oncogene expression by asbestos is ameliorated by N-acetyl-L-cysteine in mesothelial cells. Cancer Res. 55:2085-2089.
46. 2. Am. J. Physiol. 273:L1029-L1035.
47. Simeonova, P. P., W. Toriumi, C. Kommineni, M. Erkan, A. E. Munson, W. N. Rom, and M. I. Luster. 1997. Molecular regulation of IL-6 activation by asbestos in lung epithelial cells. J. Immunol. 159:3921-3928.
48. Cote, R. J., S. C. Jhanwar, S. Novick, and A. Pellicer. 1991. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas. Cancer Res. 51:5410-5416.
49. Metcalf R. A., J. A. Welsh, W. P. Bennett, M. B. Seddon, T. A. Lehman, K. Pelin, K. Linnainmaa, L. Tammilehto, K. Mattson, B. I. Gerwin, and C. C. Harris. 1992. p53 and Kirsten-ras mutations in human raesothelioma cell lines. Cancer Res. 52:2610-2615.
50. Slebos, R. J. C., R. E. Kibbelaar, O. Dalesio, A. Kooistra, J. Stam, C. J. L. M. Meijer, S. S. Wagenaar, R. G. J. R. A. Vanderschueren, N. van Znadwijk, W. J. Mooi, J. L. Bos, and S. Rodenhuis. 1990. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med. 323:561-565.
51. Mills, N. E., C. L. Fishman, W. N. Rom, N. Duhin, and D. R. Jacobson. 1995. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res. 55:1444-1447.
52. Mills, N. E., C. L. Fishman, J. Scholes, S. E. Anderson, W. N. Rom, and D. R. Jacobson. 1995. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J. Natl. Cancer Inst. 87: 1056-1060.
53. Mollo, F., E. Pira, G. Piolatto, D. Bellis, P. Burlo, A. Andreozzi, S. Bontempi, and E. Negri. 1995. Lung adenocarcinoma and indicators of asbestos exposure. Int. J. Cancer 60:289-293.
54. Raffn, E., E. Villadsen, G. Engholm, and E. Lynge. 1996. Lung cancer in asbestos cement workers in Denmark. Occup. Environ. Med. 53:399-402.
55. Churg, A. 1985. Lung cancer cell type and asbestos exposure. JAMA 253: 2984-2985.
56. Meurman, L. O., E. Pukkala, and M. Hakama. 1994. Cancer incidence among anthophyllite asbestos quarry workers in Finland. Occup. Environ. Med 51:421-125.
57. De Klerk, N., W. Musk, J. Eccles, J. Hansen, and M. Hobbs. 1996. Exposure to crocidolite and the incidence of different histological types of lung cancer. Occup. Environ. Med. 53:157-159.
58. Karjalainen, A., E. Pukkala, T. Kauppinen, and T. Partanen. 1998. Incidence of cancer among Finnish patients with asbestos-related pulmonary or pleural fibrosis. Cancer Causes Control (In press)